164 related articles for article (PubMed ID: 14594589)
1. Cushing syndrome secondary to topical glucocorticoids.
Joe EK
Dermatol Online J; 2003 Oct; 9(4):16. PubMed ID: 14594589
[TBL] [Abstract][Full Text] [Related]
2. An infantile Cushing syndrome due to misuse of topical steroid.
Siklar Z; Bostanci I; Atli O; Dallar Y
Pediatr Dermatol; 2004; 21(5):561-3. PubMed ID: 15461763
[TBL] [Abstract][Full Text] [Related]
3. Cushing's syndrome induced by misuse of moderate- to high-potency topical corticosteroids.
Coureau B; Bussières JF; Tremblay S
Ann Pharmacother; 2008 Dec; 42(12):1903-7. PubMed ID: 19017822
[TBL] [Abstract][Full Text] [Related]
4. Unrecognised Cushing's syndrome and adrenal suppression due to topical clobetasol propionate.
Young CA; Williams IR; MacFarlane IA
Br J Clin Pract; 1991; 45(1):61-2. PubMed ID: 1931550
[TBL] [Abstract][Full Text] [Related]
5. [Cushing syndrome following external glucocorticoid administration in psoriasis].
Dhein S
Z Hautkr; 1986 Feb; 61(3):161-6. PubMed ID: 3953135
[TBL] [Abstract][Full Text] [Related]
6. Two cases of Cushing's syndrome due to overuse of topical steroid in the diaper area.
Semiz S; Balci YI; Ergin S; Candemir M; Polat A
Pediatr Dermatol; 2008; 25(5):544-7. PubMed ID: 18950396
[TBL] [Abstract][Full Text] [Related]
7. Adrenal insufficiency as a result of long-term misuse of topical corticosteroids.
Böckle BC; Jara D; Nindl W; Aberer W; Sepp NT
Dermatology; 2014; 228(4):289-93. PubMed ID: 24751677
[TBL] [Abstract][Full Text] [Related]
8. Cushing syndrome, adrenal suppression and local corticosteroid use.
Hameed R; Zacharin MR
J Paediatr Child Health; 2006 Jun; 42(6):392-4. PubMed ID: 16737485
[TBL] [Abstract][Full Text] [Related]
9. Adverse drug reactions to various topical glucocorticosteroids: quantitative aspects.
Höhler T; Wörz K; Himmler V
Curr Probl Dermatol; 1993; 21():180-5. PubMed ID: 8299371
[No Abstract] [Full Text] [Related]
10. Safety of medications and hormones used in pediatric endocrinology: adrenal.
Frank GR; Speiser PW; Griffin KJ; Stratakis CA
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():134-45. PubMed ID: 16456492
[TBL] [Abstract][Full Text] [Related]
11. Iatrogenic Cushing's syndrome due to overuse of topical steroid in the diaper area.
Ozdemir A; Bas VN
J Trop Pediatr; 2014 Oct; 60(5):404-6. PubMed ID: 25016382
[No Abstract] [Full Text] [Related]
12. Cushing syndrome caused by topical corticosteroid: a case report.
Gen R; Akbay E; Sezer K
Am J Med Sci; 2007 Mar; 333(3):173-4. PubMed ID: 17496736
[TBL] [Abstract][Full Text] [Related]
13. Cushing's syndrome induced by high-potency topical corticosteroids.
Demirsoy EO; Bilen N; Aktürk AS; Kocaoğlu Ö; Mutlu GY
Int J Dermatol; 2014 Jan; 53(1):e20-2. PubMed ID: 22591336
[No Abstract] [Full Text] [Related]
14. Complications of intramuscular glucocorticoids.
Youngblood T; Cavallo A; Goldman AS; Bryan GT; Meyer WJ
Tex Med; 1987 Dec; 83(12):34-6. PubMed ID: 3424240
[No Abstract] [Full Text] [Related]
15. Pituitary-adrenal axis suppression due to topical steroid administration in an infant.
Atabek ME; Pirgon O; Unal E
Pediatr Int; 2007 Apr; 49(2):242-4. PubMed ID: 17445047
[No Abstract] [Full Text] [Related]
16. Topical Clobetasol: An Overlooked Cause of Cushing Syndrome.
Ghirardo S; De Nardi L; Tommasini A; Barbi E; Tornese G
Endocr Metab Immune Disord Drug Targets; 2021; 21(12):2300-2302. PubMed ID: 33902425
[TBL] [Abstract][Full Text] [Related]
17. Exogenous Cushing syndrome with inhaled fluticasone in a child receiving lopinavir/ritonavir.
Bhumbra NA; Sahloff EG; Oehrtman SJ; Horner JM
Ann Pharmacother; 2007 Jul; 41(7):1306-9. PubMed ID: 17535841
[TBL] [Abstract][Full Text] [Related]
18. Cushing syndrome from topical foam steroid use in an adolescent male.
Gold-von Simson G; Kohn B; Axelrod FB
Clin Pediatr (Phila); 2006; 45(1):97-100. PubMed ID: 16429224
[No Abstract] [Full Text] [Related]
19. Exogenous Cushing syndrome due to misuse of potent topical steroid.
Özgüç Çömlek F; Örüm S; Aydın S; Tütüncüler F
Pediatr Dermatol; 2018 Mar; 35(2):e121-e123. PubMed ID: 29315782
[TBL] [Abstract][Full Text] [Related]
20. Cushing syndrome from percutaneous absorption of 1% hydrocortisone ointment in Netherton syndrome.
Halverstam CP; Vachharajani A; Mallory SB
Pediatr Dermatol; 2007; 24(1):42-5. PubMed ID: 17300648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
